ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 85

Cartilaginous Uric Acid Deposition In Advanced Osteoarthritis: Innocent Bystander Or Promotor Of Cartilage Destruction?

Tim Bongartz1, Andre M Oliveira2, Rafael J Sierra3, Arlen D Hanssen3 and Michael J Taunton3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Pathology, Mayo Clinic, Rochester, MN, 3Orthopedic Surgery, Mayo Clinic, Rochester, MN

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, osteoarthritis and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Recent studies have suggested that synovial fluid uric acid could contribute to tissue inflammation, disease severity and progression of osteoarthritis (OA).  Intraarticular uric acid has been associated with OA disease severity and may promote cartilage destruction through inflammasome activation.We aimed to explore if intraarticular uric acid deposition does indeed occur in patients with osteoarthritis of the knee who have never experienced an episode of gout .

Methods:

We recruited patients with advanced osteoarthritis of the knee and no history of gout who were scheduled to undergo knee replacement surgery. All subjects underwent dual-energy scanning of the target joint.  CT images were screened for areas of uric acid deposition.During knee replacement surgery, samples of tibial and femoral condyle cartilage, menisci and synovium were obtained.  Areas of possible uric acid deposition as identified through DECT were particularly targeted for sample collection.A musculoskeletal pathologist performed light (DeGalantha and H&E stains) and polarizing microscopy and recorded the presence of uric acid crystals in a descriptive manner.

Results:

5 patients with advanced osteoarthritis of the knee did undergo DECT. In all subjects, DECT indicated areas of uric acid deposition within the joint cartilage and the menisci. In 4 of these 5 patients, histopathology exam confirmed presence of uric acid crystal clusters in the cartilage and/or menisci.  In 2 patients, uric acid deposition did also involve the synovium.  Of note, synovial fluid in all patients was negative for MSU crystals as determined through polarizing microscopy. The mean serum uric acid level was  5.7mg/dl, range 5.0-6.4 mg/dl.

Conclusion:

This pilot study did reveal evidence of cartilaginous uric acid deposition in the majority of patients with advanced osteoarthritis.Future studies will have to confirm this finding in a larger patient cohort and clarify if intracartilaginous urate crystals accelerate cartilage damage or are simply a result of matrix exposure and subsequent MSU crystallization without significant effects on disease progression.


Disclosure:

T. Bongartz,
None;

A. M. Oliveira,
None;

R. J. Sierra,
None;

A. D. Hanssen,
None;

M. J. Taunton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cartilaginous-uric-acid-deposition-in-advanced-osteoarthritis-innocent-bystander-or-promotor-of-cartilage-destruction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology